{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:58:45Z","timestamp":1761487125891},"reference-count":19,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2004,5,1]],"date-time":"2004-05-01T00:00:00Z","timestamp":1083369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2004,5]]},"DOI":"10.1016\/j.ejca.2004.01.027","type":"journal-article","created":{"date-parts":[[2004,4,3]],"date-time":"2004-04-03T10:19:28Z","timestamp":1080987568000},"page":"1188-1192","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of droperidol in the prevention of cisplatin-induced delayed emesis"],"prefix":"10.1016","volume":"40","author":[{"given":"Y.","family":"Minegishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ohmatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Niho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Kakinuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kudoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Nishiwaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2004.01.027_BIB1","first-page":"s33","article-title":"Efficacy and safety of granisetron compared with high-dose metoclopramide plus dexamethasone in patients receiving high-dose cisplatin in a single-blind study. The granisetron study group","volume":"26","author":"Chevallier","year":"1990","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejca.2004.01.027_BIB2","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/jnci\/83.16.1169","article-title":"Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis","volume":"83","author":"Warr","year":"1991","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejca.2004.01.027_BIB3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/oxfordjournals.annonc.a058927","article-title":"Oral granisetron alone and in combination with dexamethasone","volume":"5","author":"Heron","year":"1994","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejca.2004.01.027_BIB4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0140-6736(91)90555-4","article-title":"Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy","volume":"338","author":"Smith","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2004.01.027_BIB5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1200\/JCO.1991.9.4.675","article-title":"Prevention of cisplatin-induced emesis","volume":"9","author":"Roila","year":"1991","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.027_BIB6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199501053320101","article-title":"Dexamethasone, granisetron, or both for the prevention of nausea and vomiting during chemotherapy for cancer","volume":"332","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2004.01.027_BIB7","first-page":"469","article-title":"Trial of droperidol as an antiemetic in cisplatin chemotherapy","volume":"70","author":"Kelley","year":"1986","journal-title":"Cancer Treat Rep."},{"key":"10.1016\/j.ejca.2004.01.027_BIB8","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/1097-0142(19880415)61:8<1508::AID-CNCR2820610806>3.0.CO;2-H","article-title":"Combination antiemetics for cisplatin chemotherapy","volume":"61","author":"Sridhar","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2004.01.027_BIB9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000226908","article-title":"Antiemetic efficacy of droperidol or metoclopramide combined with dexamethasone and diphenhydramine. Randomized open parallel study","volume":"48","author":"Aapro","year":"1991","journal-title":"Oncology"},{"key":"10.1016\/j.ejca.2004.01.027_BIB10","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1056\/NEJM199304153281502","article-title":"Ondansetron plus metopimazine compared with ondansetron alone in patients receiving moderately emetogenic chemotherapy","volume":"328","author":"Herrstedt","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejca.2004.01.027_BIB11","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.1997.15.4.1690","article-title":"Randomized, double-blind comparison of ondansetron plus metopimazine as antiemetic prophylaxis during platinum-based chemotherapy in patients with cancer","volume":"15","author":"Herrstedt","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.027_BIB12","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1200\/JCO.1995.13.9.2408","article-title":"Oral ondansetron for the control of cisplatin-induced delayed emesis","volume":"13","author":"Navari","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.027_BIB13","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/1097-0142(19951115)76:10<1821::AID-CNCR2820761022>3.0.CO;2-Y","article-title":"Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting induced by cisplatin-based chemotherapy","volume":"76","author":"Gebbia","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2004.01.027_BIB14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1023\/A:1008256115221","article-title":"Control of delayed nausea and vomiting with granisetron plus dexamethasone or dexamethasone alone in patients receiving highly emetogenic chemotherapy","volume":"9","author":"Goedhals","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejca.2004.01.027_BIB15","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/S0959-8049(01)00326-4","article-title":"Randomised comparison of ondansetron plus dexamethasone with dexamethasone alone for the control of delayed cisplatin-induced emesis","volume":"37","author":"Tukada","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejca.2004.01.027_BIB16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1200\/JCO.1997.15.1.124","article-title":"Ondansetron versus metoclopramide, both combined with dexamethasone, in the prevention of cisplatin-induced delayed emesis","volume":"15","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.027_BIB17","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1200\/JCO.1998.16.3.1174","article-title":"Use of dexamethasone and granisetron in the control of delayed emesis for patients who receive highly emetogenic chemotherapy. National Cancer Institute of Canada Clinical Trial Group","volume":"16","author":"Latreille","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.027_BIB18","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1200\/JCO.2001.19.6.1759","article-title":"Prevention of cisplatin-induced emesis by the oral neurokinin-1 antagonist, MK-869, in combination with granisetron and dexamethasone or with dexamethasone alone","volume":"19","author":"Campos","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejca.2004.01.027_BIB19","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1056\/NEJM199901213400304","article-title":"Reduction of cisplatin-induced emesis by a selective neurokinin-1 receptor antagonist","volume":"340","author":"Navari","year":"1999","journal-title":"N. Engl. J. Med."}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804904001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804904001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T08:20:01Z","timestamp":1550132401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804904001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,5]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,5]]}},"alternative-id":["S0959804904001650"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2004.01.027","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2004,5]]}}}